The paper discusses the pportunities and risks that institutions should consider when investing in China���s A-Share and private equity markets.
Is China still the wildcard in domestic equity markets?
What's going on in the world of late cycle investing, unicorn IPOs, and growth in the private equity market?
Do we still see promise in emerging market growth?
What opportunities are available in today���s venture growth markets?
With investors looking to achieve alpha, reduce volatility and minimize costs, can smart beta achieve the perfect balance in today's environment?